MOLECULAR NUTRITION & FOOD RESEARCH-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2142565, encodeId=ab992142565f9, content=请问大家有碰到一个审稿人的情况吗？大修回了以后多久有结果？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de2a6480732, createdName=ms6000000386866005, createdTime=Tue Jun 13 14:48:34 CST 2023, time=2023-06-13, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1205857, encodeId=dc64120585e5c, content=请教大家一般大修回去多久收到消息呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/KUQlIP30FJNzX6JDFPic6BAPBWV3M81mdCIBnvPqW5ZkxQIYMe1JF1Q2Okn5mSJQtG4B3jkiaXyxlCrEhYbu0ickQ/0, createdBy=9e781671550, createdName=cfynocry, createdTime=Fri Mar 25 14:51:41 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2142563, encodeId=1abc214256368, content=请问有碰到只有一个审稿人的情况么？大修回去多久有消息的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de2a6480732, createdName=ms6000000386866005, createdTime=Tue Jun 13 14:45:11 CST 2023, time=2023-06-13, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=963629, encodeId=22779636292e, content=审稿速度:3.0 | 投稿命中率:50.0 | 版面费用:588.0 偏重的研究方向：肠道菌群;糖尿病 经验分享：2020年12月初投稿，半个月后要求拒稿重投。于是，2021年1月4号重新投稿，2月2号审稿意见返回，3月13号返回修改稿，4月28日接收。审稿人很细心，注重方法描述，按照审稿人的要求认真修改就好了。感恩遇到好编辑和好的审稿人！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJp0sD8Z3gbQkzM1Y9IiaGB021QlfcibqTSZ43dKewmmXh9JbSicKR8XoicPAzichzQOP3CFn9RrAmuk1w/132, createdBy=d2602052909, createdName=liyahan, createdTime=Sat May 08 09:29:15 CST 2021, time=2021-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120684, encodeId=b29c2120684ad, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47618190126, createdName=ms9000000817557932, createdTime=Tue Mar 21 05:21:25 CST 2023, time=2023-03-21, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=849818, encodeId=b72b84981857, content=投稿一个月后被拒，建议修改后重投，修改后重投之后半个月接收，编辑的意见很中肯，对实验描述要求高，可惜现在降到了2区，希望努力一下明年重回1区 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62635414138, createdName=ms5054295132918558, createdTime=Fri Feb 22 10:41:27 CST 2019, time=2019-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102200, encodeId=b3d2210220015, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：营养 经验分享：10.14日投稿，一周内送外审，11.17日拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91a75702467, createdName=ms4000001330996087, createdTime=Wed Nov 23 16:48:41 CST 2022, time=2022-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181167, encodeId=bb89118116e0b, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：糖尿病 经验分享：投稿一周后分配编辑，分配编辑后到现在还没有消息，请问有分配编辑是Perets, Ekaterina的嘛？一般多久能回来？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc4e5617036, createdName=ms9000001896838190, createdTime=Thu Jan 06 08:43:38 CST 2022, time=2022-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102205, encodeId=35aa21022054d, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：食品营养 经验分享：10.14投稿，投稿后显示 under review，一周内送审ED变为一位专家。11.17返回，拒稿。。期刊创新性要求较高，实验要求完整性较高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91a75702467, createdName=ms4000001330996087, createdTime=Wed Nov 23 16:56:29 CST 2022, time=2022-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=856211, encodeId=a43385621146, content=我的研究方向是营养活性成分与慢性病防治，data也算挺多的，一共8个figure，内容包括体外细胞实验和人群的随机对照干预试验（人群这部分只有一张figure)，之前投了atvb，第二天就秒拒了，后来改投mnfr。2019年6月18日提交投稿，7月22日返修意见。一共2个reviewer，第一个reviewer问了6个问题，都是一些疑问和后续研究的建议（比如建议在已经患有血栓性疾病的病人上进行探讨，我们是rct研究，对高脂血症患者进行干预了6个月，所以只能回答同意审稿人的意见，后续会作进一的探讨），没让补实验；第二个审稿人问了3个小问题，包括一个疑问和2点修改的建议，没有让补实验。editor要求2个月内返回response，我8月22号返回，8月29号就直接接收了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8bf35413988, createdName=ms5619336576777824, createdTime=Thu Dec 26 11:40:18 CST 2019, time=2019-12-26, status=1, ipAttribution=)]

2023-06-13 ms6000000386866005 来自湖北省

请问大家有碰到一个审稿人的情况吗？大修回了以后多久有结果？

24 8

展开8条回复

[GetPortalCommentsPageByObjectIdResponse(id=2142565, encodeId=ab992142565f9, content=请问大家有碰到一个审稿人的情况吗？大修回了以后多久有结果？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de2a6480732, createdName=ms6000000386866005, createdTime=Tue Jun 13 14:48:34 CST 2023, time=2023-06-13, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1205857, encodeId=dc64120585e5c, content=请教大家一般大修回去多久收到消息呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/KUQlIP30FJNzX6JDFPic6BAPBWV3M81mdCIBnvPqW5ZkxQIYMe1JF1Q2Okn5mSJQtG4B3jkiaXyxlCrEhYbu0ickQ/0, createdBy=9e781671550, createdName=cfynocry, createdTime=Fri Mar 25 14:51:41 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2142563, encodeId=1abc214256368, content=请问有碰到只有一个审稿人的情况么？大修回去多久有消息的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de2a6480732, createdName=ms6000000386866005, createdTime=Tue Jun 13 14:45:11 CST 2023, time=2023-06-13, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=963629, encodeId=22779636292e, content=审稿速度:3.0 | 投稿命中率:50.0 | 版面费用:588.0 偏重的研究方向：肠道菌群;糖尿病 经验分享：2020年12月初投稿，半个月后要求拒稿重投。于是，2021年1月4号重新投稿，2月2号审稿意见返回，3月13号返回修改稿，4月28日接收。审稿人很细心，注重方法描述，按照审稿人的要求认真修改就好了。感恩遇到好编辑和好的审稿人！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJp0sD8Z3gbQkzM1Y9IiaGB021QlfcibqTSZ43dKewmmXh9JbSicKR8XoicPAzichzQOP3CFn9RrAmuk1w/132, createdBy=d2602052909, createdName=liyahan, createdTime=Sat May 08 09:29:15 CST 2021, time=2021-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120684, encodeId=b29c2120684ad, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47618190126, createdName=ms9000000817557932, createdTime=Tue Mar 21 05:21:25 CST 2023, time=2023-03-21, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=849818, encodeId=b72b84981857, content=投稿一个月后被拒，建议修改后重投，修改后重投之后半个月接收，编辑的意见很中肯，对实验描述要求高，可惜现在降到了2区，希望努力一下明年重回1区 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62635414138, createdName=ms5054295132918558, createdTime=Fri Feb 22 10:41:27 CST 2019, time=2019-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102200, encodeId=b3d2210220015, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：营养 经验分享：10.14日投稿，一周内送外审，11.17日拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91a75702467, createdName=ms4000001330996087, createdTime=Wed Nov 23 16:48:41 CST 2022, time=2022-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181167, encodeId=bb89118116e0b, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：糖尿病 经验分享：投稿一周后分配编辑，分配编辑后到现在还没有消息，请问有分配编辑是Perets, Ekaterina的嘛？一般多久能回来？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc4e5617036, createdName=ms9000001896838190, createdTime=Thu Jan 06 08:43:38 CST 2022, time=2022-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102205, encodeId=35aa21022054d, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：食品营养 经验分享：10.14投稿，投稿后显示 under review，一周内送审ED变为一位专家。11.17返回，拒稿。。期刊创新性要求较高，实验要求完整性较高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91a75702467, createdName=ms4000001330996087, createdTime=Wed Nov 23 16:56:29 CST 2022, time=2022-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=856211, encodeId=a43385621146, content=我的研究方向是营养活性成分与慢性病防治，data也算挺多的，一共8个figure，内容包括体外细胞实验和人群的随机对照干预试验（人群这部分只有一张figure)，之前投了atvb，第二天就秒拒了，后来改投mnfr。2019年6月18日提交投稿，7月22日返修意见。一共2个reviewer，第一个reviewer问了6个问题，都是一些疑问和后续研究的建议（比如建议在已经患有血栓性疾病的病人上进行探讨，我们是rct研究，对高脂血症患者进行干预了6个月，所以只能回答同意审稿人的意见，后续会作进一的探讨），没让补实验；第二个审稿人问了3个小问题，包括一个疑问和2点修改的建议，没有让补实验。editor要求2个月内返回response，我8月22号返回，8月29号就直接接收了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8bf35413988, createdName=ms5619336576777824, createdTime=Thu Dec 26 11:40:18 CST 2019, time=2019-12-26, status=1, ipAttribution=)]

2022-03-25 cfynocry

请教大家一般大修回去多久收到消息呀

30 11

展开11条回复

[GetPortalCommentsPageByObjectIdResponse(id=2142565, encodeId=ab992142565f9, content=请问大家有碰到一个审稿人的情况吗？大修回了以后多久有结果？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de2a6480732, createdName=ms6000000386866005, createdTime=Tue Jun 13 14:48:34 CST 2023, time=2023-06-13, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1205857, encodeId=dc64120585e5c, content=请教大家一般大修回去多久收到消息呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/KUQlIP30FJNzX6JDFPic6BAPBWV3M81mdCIBnvPqW5ZkxQIYMe1JF1Q2Okn5mSJQtG4B3jkiaXyxlCrEhYbu0ickQ/0, createdBy=9e781671550, createdName=cfynocry, createdTime=Fri Mar 25 14:51:41 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2142563, encodeId=1abc214256368, content=请问有碰到只有一个审稿人的情况么？大修回去多久有消息的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de2a6480732, createdName=ms6000000386866005, createdTime=Tue Jun 13 14:45:11 CST 2023, time=2023-06-13, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=963629, encodeId=22779636292e, content=审稿速度:3.0 | 投稿命中率:50.0 | 版面费用:588.0 偏重的研究方向：肠道菌群;糖尿病 经验分享：2020年12月初投稿，半个月后要求拒稿重投。于是，2021年1月4号重新投稿，2月2号审稿意见返回，3月13号返回修改稿，4月28日接收。审稿人很细心，注重方法描述，按照审稿人的要求认真修改就好了。感恩遇到好编辑和好的审稿人！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJp0sD8Z3gbQkzM1Y9IiaGB021QlfcibqTSZ43dKewmmXh9JbSicKR8XoicPAzichzQOP3CFn9RrAmuk1w/132, createdBy=d2602052909, createdName=liyahan, createdTime=Sat May 08 09:29:15 CST 2021, time=2021-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120684, encodeId=b29c2120684ad, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47618190126, createdName=ms9000000817557932, createdTime=Tue Mar 21 05:21:25 CST 2023, time=2023-03-21, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=849818, encodeId=b72b84981857, content=投稿一个月后被拒，建议修改后重投，修改后重投之后半个月接收，编辑的意见很中肯，对实验描述要求高，可惜现在降到了2区，希望努力一下明年重回1区 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62635414138, createdName=ms5054295132918558, createdTime=Fri Feb 22 10:41:27 CST 2019, time=2019-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102200, encodeId=b3d2210220015, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：营养 经验分享：10.14日投稿，一周内送外审，11.17日拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91a75702467, createdName=ms4000001330996087, createdTime=Wed Nov 23 16:48:41 CST 2022, time=2022-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181167, encodeId=bb89118116e0b, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：糖尿病 经验分享：投稿一周后分配编辑，分配编辑后到现在还没有消息，请问有分配编辑是Perets, Ekaterina的嘛？一般多久能回来？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc4e5617036, createdName=ms9000001896838190, createdTime=Thu Jan 06 08:43:38 CST 2022, time=2022-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102205, encodeId=35aa21022054d, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：食品营养 经验分享：10.14投稿，投稿后显示 under review，一周内送审ED变为一位专家。11.17返回，拒稿。。期刊创新性要求较高，实验要求完整性较高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91a75702467, createdName=ms4000001330996087, createdTime=Wed Nov 23 16:56:29 CST 2022, time=2022-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=856211, encodeId=a43385621146, content=我的研究方向是营养活性成分与慢性病防治，data也算挺多的，一共8个figure，内容包括体外细胞实验和人群的随机对照干预试验（人群这部分只有一张figure)，之前投了atvb，第二天就秒拒了，后来改投mnfr。2019年6月18日提交投稿，7月22日返修意见。一共2个reviewer，第一个reviewer问了6个问题，都是一些疑问和后续研究的建议（比如建议在已经患有血栓性疾病的病人上进行探讨，我们是rct研究，对高脂血症患者进行干预了6个月，所以只能回答同意审稿人的意见，后续会作进一的探讨），没让补实验；第二个审稿人问了3个小问题，包括一个疑问和2点修改的建议，没有让补实验。editor要求2个月内返回response，我8月22号返回，8月29号就直接接收了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8bf35413988, createdName=ms5619336576777824, createdTime=Thu Dec 26 11:40:18 CST 2019, time=2019-12-26, status=1, ipAttribution=)]

2023-06-13 ms6000000386866005 来自湖北省

请问有碰到只有一个审稿人的情况么？大修回去多久有消息的？

9 0

[GetPortalCommentsPageByObjectIdResponse(id=2142565, encodeId=ab992142565f9, content=请问大家有碰到一个审稿人的情况吗？大修回了以后多久有结果？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de2a6480732, createdName=ms6000000386866005, createdTime=Tue Jun 13 14:48:34 CST 2023, time=2023-06-13, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1205857, encodeId=dc64120585e5c, content=请教大家一般大修回去多久收到消息呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/KUQlIP30FJNzX6JDFPic6BAPBWV3M81mdCIBnvPqW5ZkxQIYMe1JF1Q2Okn5mSJQtG4B3jkiaXyxlCrEhYbu0ickQ/0, createdBy=9e781671550, createdName=cfynocry, createdTime=Fri Mar 25 14:51:41 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2142563, encodeId=1abc214256368, content=请问有碰到只有一个审稿人的情况么？大修回去多久有消息的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de2a6480732, createdName=ms6000000386866005, createdTime=Tue Jun 13 14:45:11 CST 2023, time=2023-06-13, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=963629, encodeId=22779636292e, content=审稿速度:3.0 | 投稿命中率:50.0 | 版面费用:588.0 偏重的研究方向：肠道菌群;糖尿病 经验分享：2020年12月初投稿，半个月后要求拒稿重投。于是，2021年1月4号重新投稿，2月2号审稿意见返回，3月13号返回修改稿，4月28日接收。审稿人很细心，注重方法描述，按照审稿人的要求认真修改就好了。感恩遇到好编辑和好的审稿人！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJp0sD8Z3gbQkzM1Y9IiaGB021QlfcibqTSZ43dKewmmXh9JbSicKR8XoicPAzichzQOP3CFn9RrAmuk1w/132, createdBy=d2602052909, createdName=liyahan, createdTime=Sat May 08 09:29:15 CST 2021, time=2021-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120684, encodeId=b29c2120684ad, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47618190126, createdName=ms9000000817557932, createdTime=Tue Mar 21 05:21:25 CST 2023, time=2023-03-21, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=849818, encodeId=b72b84981857, content=投稿一个月后被拒，建议修改后重投，修改后重投之后半个月接收，编辑的意见很中肯，对实验描述要求高，可惜现在降到了2区，希望努力一下明年重回1区 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62635414138, createdName=ms5054295132918558, createdTime=Fri Feb 22 10:41:27 CST 2019, time=2019-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102200, encodeId=b3d2210220015, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：营养 经验分享：10.14日投稿，一周内送外审，11.17日拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91a75702467, createdName=ms4000001330996087, createdTime=Wed Nov 23 16:48:41 CST 2022, time=2022-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181167, encodeId=bb89118116e0b, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：糖尿病 经验分享：投稿一周后分配编辑，分配编辑后到现在还没有消息，请问有分配编辑是Perets, Ekaterina的嘛？一般多久能回来？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc4e5617036, createdName=ms9000001896838190, createdTime=Thu Jan 06 08:43:38 CST 2022, time=2022-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102205, encodeId=35aa21022054d, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：食品营养 经验分享：10.14投稿，投稿后显示 under review，一周内送审ED变为一位专家。11.17返回，拒稿。。期刊创新性要求较高，实验要求完整性较高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91a75702467, createdName=ms4000001330996087, createdTime=Wed Nov 23 16:56:29 CST 2022, time=2022-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=856211, encodeId=a43385621146, content=我的研究方向是营养活性成分与慢性病防治，data也算挺多的，一共8个figure，内容包括体外细胞实验和人群的随机对照干预试验（人群这部分只有一张figure)，之前投了atvb，第二天就秒拒了，后来改投mnfr。2019年6月18日提交投稿，7月22日返修意见。一共2个reviewer，第一个reviewer问了6个问题，都是一些疑问和后续研究的建议（比如建议在已经患有血栓性疾病的病人上进行探讨，我们是rct研究，对高脂血症患者进行干预了6个月，所以只能回答同意审稿人的意见，后续会作进一的探讨），没让补实验；第二个审稿人问了3个小问题，包括一个疑问和2点修改的建议，没有让补实验。editor要求2个月内返回response，我8月22号返回，8月29号就直接接收了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8bf35413988, createdName=ms5619336576777824, createdTime=Thu Dec 26 11:40:18 CST 2019, time=2019-12-26, status=1, ipAttribution=)]

2021-05-08 liyahan

审稿速度:3.0 | 投稿命中率:50.0 | 版面费用:588.0
偏重的研究方向：肠道菌群;糖尿病
经验分享：2020年12月初投稿，半个月后要求拒稿重投。于是，2021年1月4号重新投稿，2月2号审稿意见返回，3月13号返回修改稿，4月28日接收。审稿人很细心，注重方法描述，按照审稿人的要求认真修改就好了。感恩遇到好编辑和好的审稿人！

50 16

展开16条回复

[GetPortalCommentsPageByObjectIdResponse(id=2142565, encodeId=ab992142565f9, content=请问大家有碰到一个审稿人的情况吗？大修回了以后多久有结果？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de2a6480732, createdName=ms6000000386866005, createdTime=Tue Jun 13 14:48:34 CST 2023, time=2023-06-13, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1205857, encodeId=dc64120585e5c, content=请教大家一般大修回去多久收到消息呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/KUQlIP30FJNzX6JDFPic6BAPBWV3M81mdCIBnvPqW5ZkxQIYMe1JF1Q2Okn5mSJQtG4B3jkiaXyxlCrEhYbu0ickQ/0, createdBy=9e781671550, createdName=cfynocry, createdTime=Fri Mar 25 14:51:41 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2142563, encodeId=1abc214256368, content=请问有碰到只有一个审稿人的情况么？大修回去多久有消息的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de2a6480732, createdName=ms6000000386866005, createdTime=Tue Jun 13 14:45:11 CST 2023, time=2023-06-13, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=963629, encodeId=22779636292e, content=审稿速度:3.0 | 投稿命中率:50.0 | 版面费用:588.0 偏重的研究方向：肠道菌群;糖尿病 经验分享：2020年12月初投稿，半个月后要求拒稿重投。于是，2021年1月4号重新投稿，2月2号审稿意见返回，3月13号返回修改稿，4月28日接收。审稿人很细心，注重方法描述，按照审稿人的要求认真修改就好了。感恩遇到好编辑和好的审稿人！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJp0sD8Z3gbQkzM1Y9IiaGB021QlfcibqTSZ43dKewmmXh9JbSicKR8XoicPAzichzQOP3CFn9RrAmuk1w/132, createdBy=d2602052909, createdName=liyahan, createdTime=Sat May 08 09:29:15 CST 2021, time=2021-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120684, encodeId=b29c2120684ad, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47618190126, createdName=ms9000000817557932, createdTime=Tue Mar 21 05:21:25 CST 2023, time=2023-03-21, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=849818, encodeId=b72b84981857, content=投稿一个月后被拒，建议修改后重投，修改后重投之后半个月接收，编辑的意见很中肯，对实验描述要求高，可惜现在降到了2区，希望努力一下明年重回1区 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62635414138, createdName=ms5054295132918558, createdTime=Fri Feb 22 10:41:27 CST 2019, time=2019-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102200, encodeId=b3d2210220015, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：营养 经验分享：10.14日投稿，一周内送外审，11.17日拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91a75702467, createdName=ms4000001330996087, createdTime=Wed Nov 23 16:48:41 CST 2022, time=2022-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181167, encodeId=bb89118116e0b, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：糖尿病 经验分享：投稿一周后分配编辑，分配编辑后到现在还没有消息，请问有分配编辑是Perets, Ekaterina的嘛？一般多久能回来？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc4e5617036, createdName=ms9000001896838190, createdTime=Thu Jan 06 08:43:38 CST 2022, time=2022-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102205, encodeId=35aa21022054d, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：食品营养 经验分享：10.14投稿，投稿后显示 under review，一周内送审ED变为一位专家。11.17返回，拒稿。。期刊创新性要求较高，实验要求完整性较高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91a75702467, createdName=ms4000001330996087, createdTime=Wed Nov 23 16:56:29 CST 2022, time=2022-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=856211, encodeId=a43385621146, content=我的研究方向是营养活性成分与慢性病防治，data也算挺多的，一共8个figure，内容包括体外细胞实验和人群的随机对照干预试验（人群这部分只有一张figure)，之前投了atvb，第二天就秒拒了，后来改投mnfr。2019年6月18日提交投稿，7月22日返修意见。一共2个reviewer，第一个reviewer问了6个问题，都是一些疑问和后续研究的建议（比如建议在已经患有血栓性疾病的病人上进行探讨，我们是rct研究，对高脂血症患者进行干预了6个月，所以只能回答同意审稿人的意见，后续会作进一的探讨），没让补实验；第二个审稿人问了3个小问题，包括一个疑问和2点修改的建议，没有让补实验。editor要求2个月内返回response，我8月22号返回，8月29号就直接接收了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8bf35413988, createdName=ms5619336576777824, createdTime=Thu Dec 26 11:40:18 CST 2019, time=2019-12-26, status=1, ipAttribution=)]

2023-03-21 ms9000000817557932 来自四川省

审稿速度:2.0 | 投稿命中率:75.0
经验分享：无

11 0

[GetPortalCommentsPageByObjectIdResponse(id=2142565, encodeId=ab992142565f9, content=请问大家有碰到一个审稿人的情况吗？大修回了以后多久有结果？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de2a6480732, createdName=ms6000000386866005, createdTime=Tue Jun 13 14:48:34 CST 2023, time=2023-06-13, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1205857, encodeId=dc64120585e5c, content=请教大家一般大修回去多久收到消息呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/KUQlIP30FJNzX6JDFPic6BAPBWV3M81mdCIBnvPqW5ZkxQIYMe1JF1Q2Okn5mSJQtG4B3jkiaXyxlCrEhYbu0ickQ/0, createdBy=9e781671550, createdName=cfynocry, createdTime=Fri Mar 25 14:51:41 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2142563, encodeId=1abc214256368, content=请问有碰到只有一个审稿人的情况么？大修回去多久有消息的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de2a6480732, createdName=ms6000000386866005, createdTime=Tue Jun 13 14:45:11 CST 2023, time=2023-06-13, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=963629, encodeId=22779636292e, content=审稿速度:3.0 | 投稿命中率:50.0 | 版面费用:588.0 偏重的研究方向：肠道菌群;糖尿病 经验分享：2020年12月初投稿，半个月后要求拒稿重投。于是，2021年1月4号重新投稿，2月2号审稿意见返回，3月13号返回修改稿，4月28日接收。审稿人很细心，注重方法描述，按照审稿人的要求认真修改就好了。感恩遇到好编辑和好的审稿人！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJp0sD8Z3gbQkzM1Y9IiaGB021QlfcibqTSZ43dKewmmXh9JbSicKR8XoicPAzichzQOP3CFn9RrAmuk1w/132, createdBy=d2602052909, createdName=liyahan, createdTime=Sat May 08 09:29:15 CST 2021, time=2021-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120684, encodeId=b29c2120684ad, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47618190126, createdName=ms9000000817557932, createdTime=Tue Mar 21 05:21:25 CST 2023, time=2023-03-21, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=849818, encodeId=b72b84981857, content=投稿一个月后被拒，建议修改后重投，修改后重投之后半个月接收，编辑的意见很中肯，对实验描述要求高，可惜现在降到了2区，希望努力一下明年重回1区 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62635414138, createdName=ms5054295132918558, createdTime=Fri Feb 22 10:41:27 CST 2019, time=2019-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102200, encodeId=b3d2210220015, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：营养 经验分享：10.14日投稿，一周内送外审，11.17日拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91a75702467, createdName=ms4000001330996087, createdTime=Wed Nov 23 16:48:41 CST 2022, time=2022-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181167, encodeId=bb89118116e0b, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：糖尿病 经验分享：投稿一周后分配编辑，分配编辑后到现在还没有消息，请问有分配编辑是Perets, Ekaterina的嘛？一般多久能回来？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc4e5617036, createdName=ms9000001896838190, createdTime=Thu Jan 06 08:43:38 CST 2022, time=2022-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102205, encodeId=35aa21022054d, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：食品营养 经验分享：10.14投稿，投稿后显示 under review，一周内送审ED变为一位专家。11.17返回，拒稿。。期刊创新性要求较高，实验要求完整性较高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91a75702467, createdName=ms4000001330996087, createdTime=Wed Nov 23 16:56:29 CST 2022, time=2022-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=856211, encodeId=a43385621146, content=我的研究方向是营养活性成分与慢性病防治，data也算挺多的，一共8个figure，内容包括体外细胞实验和人群的随机对照干预试验（人群这部分只有一张figure)，之前投了atvb，第二天就秒拒了，后来改投mnfr。2019年6月18日提交投稿，7月22日返修意见。一共2个reviewer，第一个reviewer问了6个问题，都是一些疑问和后续研究的建议（比如建议在已经患有血栓性疾病的病人上进行探讨，我们是rct研究，对高脂血症患者进行干预了6个月，所以只能回答同意审稿人的意见，后续会作进一的探讨），没让补实验；第二个审稿人问了3个小问题，包括一个疑问和2点修改的建议，没有让补实验。editor要求2个月内返回response，我8月22号返回，8月29号就直接接收了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8bf35413988, createdName=ms5619336576777824, createdTime=Thu Dec 26 11:40:18 CST 2019, time=2019-12-26, status=1, ipAttribution=)]

2019-02-22 ms5054295132918558

投稿一个月后被拒，建议修改后重投，修改后重投之后半个月接收，编辑的意见很中肯，对实验描述要求高，可惜现在降到了2区，希望努力一下明年重回1区

95 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2142565, encodeId=ab992142565f9, content=请问大家有碰到一个审稿人的情况吗？大修回了以后多久有结果？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de2a6480732, createdName=ms6000000386866005, createdTime=Tue Jun 13 14:48:34 CST 2023, time=2023-06-13, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1205857, encodeId=dc64120585e5c, content=请教大家一般大修回去多久收到消息呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/KUQlIP30FJNzX6JDFPic6BAPBWV3M81mdCIBnvPqW5ZkxQIYMe1JF1Q2Okn5mSJQtG4B3jkiaXyxlCrEhYbu0ickQ/0, createdBy=9e781671550, createdName=cfynocry, createdTime=Fri Mar 25 14:51:41 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2142563, encodeId=1abc214256368, content=请问有碰到只有一个审稿人的情况么？大修回去多久有消息的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de2a6480732, createdName=ms6000000386866005, createdTime=Tue Jun 13 14:45:11 CST 2023, time=2023-06-13, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=963629, encodeId=22779636292e, content=审稿速度:3.0 | 投稿命中率:50.0 | 版面费用:588.0 偏重的研究方向：肠道菌群;糖尿病 经验分享：2020年12月初投稿，半个月后要求拒稿重投。于是，2021年1月4号重新投稿，2月2号审稿意见返回，3月13号返回修改稿，4月28日接收。审稿人很细心，注重方法描述，按照审稿人的要求认真修改就好了。感恩遇到好编辑和好的审稿人！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJp0sD8Z3gbQkzM1Y9IiaGB021QlfcibqTSZ43dKewmmXh9JbSicKR8XoicPAzichzQOP3CFn9RrAmuk1w/132, createdBy=d2602052909, createdName=liyahan, createdTime=Sat May 08 09:29:15 CST 2021, time=2021-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120684, encodeId=b29c2120684ad, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47618190126, createdName=ms9000000817557932, createdTime=Tue Mar 21 05:21:25 CST 2023, time=2023-03-21, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=849818, encodeId=b72b84981857, content=投稿一个月后被拒，建议修改后重投，修改后重投之后半个月接收，编辑的意见很中肯，对实验描述要求高，可惜现在降到了2区，希望努力一下明年重回1区 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62635414138, createdName=ms5054295132918558, createdTime=Fri Feb 22 10:41:27 CST 2019, time=2019-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102200, encodeId=b3d2210220015, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：营养 经验分享：10.14日投稿，一周内送外审，11.17日拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91a75702467, createdName=ms4000001330996087, createdTime=Wed Nov 23 16:48:41 CST 2022, time=2022-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181167, encodeId=bb89118116e0b, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：糖尿病 经验分享：投稿一周后分配编辑，分配编辑后到现在还没有消息，请问有分配编辑是Perets, Ekaterina的嘛？一般多久能回来？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc4e5617036, createdName=ms9000001896838190, createdTime=Thu Jan 06 08:43:38 CST 2022, time=2022-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102205, encodeId=35aa21022054d, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：食品营养 经验分享：10.14投稿，投稿后显示 under review，一周内送审ED变为一位专家。11.17返回，拒稿。。期刊创新性要求较高，实验要求完整性较高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91a75702467, createdName=ms4000001330996087, createdTime=Wed Nov 23 16:56:29 CST 2022, time=2022-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=856211, encodeId=a43385621146, content=我的研究方向是营养活性成分与慢性病防治，data也算挺多的，一共8个figure，内容包括体外细胞实验和人群的随机对照干预试验（人群这部分只有一张figure)，之前投了atvb，第二天就秒拒了，后来改投mnfr。2019年6月18日提交投稿，7月22日返修意见。一共2个reviewer，第一个reviewer问了6个问题，都是一些疑问和后续研究的建议（比如建议在已经患有血栓性疾病的病人上进行探讨，我们是rct研究，对高脂血症患者进行干预了6个月，所以只能回答同意审稿人的意见，后续会作进一的探讨），没让补实验；第二个审稿人问了3个小问题，包括一个疑问和2点修改的建议，没有让补实验。editor要求2个月内返回response，我8月22号返回，8月29号就直接接收了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8bf35413988, createdName=ms5619336576777824, createdTime=Thu Dec 26 11:40:18 CST 2019, time=2019-12-26, status=1, ipAttribution=)]

2022-11-23 ms4000001330996087

审稿速度:1.0 | 投稿命中率:25.0
偏重的研究方向：营养
经验分享：10.14日投稿，一周内送外审，11.17日拒稿。

16 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2142565, encodeId=ab992142565f9, content=请问大家有碰到一个审稿人的情况吗？大修回了以后多久有结果？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de2a6480732, createdName=ms6000000386866005, createdTime=Tue Jun 13 14:48:34 CST 2023, time=2023-06-13, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1205857, encodeId=dc64120585e5c, content=请教大家一般大修回去多久收到消息呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/KUQlIP30FJNzX6JDFPic6BAPBWV3M81mdCIBnvPqW5ZkxQIYMe1JF1Q2Okn5mSJQtG4B3jkiaXyxlCrEhYbu0ickQ/0, createdBy=9e781671550, createdName=cfynocry, createdTime=Fri Mar 25 14:51:41 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2142563, encodeId=1abc214256368, content=请问有碰到只有一个审稿人的情况么？大修回去多久有消息的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de2a6480732, createdName=ms6000000386866005, createdTime=Tue Jun 13 14:45:11 CST 2023, time=2023-06-13, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=963629, encodeId=22779636292e, content=审稿速度:3.0 | 投稿命中率:50.0 | 版面费用:588.0 偏重的研究方向：肠道菌群;糖尿病 经验分享：2020年12月初投稿，半个月后要求拒稿重投。于是，2021年1月4号重新投稿，2月2号审稿意见返回，3月13号返回修改稿，4月28日接收。审稿人很细心，注重方法描述，按照审稿人的要求认真修改就好了。感恩遇到好编辑和好的审稿人！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJp0sD8Z3gbQkzM1Y9IiaGB021QlfcibqTSZ43dKewmmXh9JbSicKR8XoicPAzichzQOP3CFn9RrAmuk1w/132, createdBy=d2602052909, createdName=liyahan, createdTime=Sat May 08 09:29:15 CST 2021, time=2021-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120684, encodeId=b29c2120684ad, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47618190126, createdName=ms9000000817557932, createdTime=Tue Mar 21 05:21:25 CST 2023, time=2023-03-21, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=849818, encodeId=b72b84981857, content=投稿一个月后被拒，建议修改后重投，修改后重投之后半个月接收，编辑的意见很中肯，对实验描述要求高，可惜现在降到了2区，希望努力一下明年重回1区 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62635414138, createdName=ms5054295132918558, createdTime=Fri Feb 22 10:41:27 CST 2019, time=2019-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102200, encodeId=b3d2210220015, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：营养 经验分享：10.14日投稿，一周内送外审，11.17日拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91a75702467, createdName=ms4000001330996087, createdTime=Wed Nov 23 16:48:41 CST 2022, time=2022-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181167, encodeId=bb89118116e0b, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：糖尿病 经验分享：投稿一周后分配编辑，分配编辑后到现在还没有消息，请问有分配编辑是Perets, Ekaterina的嘛？一般多久能回来？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc4e5617036, createdName=ms9000001896838190, createdTime=Thu Jan 06 08:43:38 CST 2022, time=2022-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102205, encodeId=35aa21022054d, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：食品营养 经验分享：10.14投稿，投稿后显示 under review，一周内送审ED变为一位专家。11.17返回，拒稿。。期刊创新性要求较高，实验要求完整性较高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91a75702467, createdName=ms4000001330996087, createdTime=Wed Nov 23 16:56:29 CST 2022, time=2022-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=856211, encodeId=a43385621146, content=我的研究方向是营养活性成分与慢性病防治，data也算挺多的，一共8个figure，内容包括体外细胞实验和人群的随机对照干预试验（人群这部分只有一张figure)，之前投了atvb，第二天就秒拒了，后来改投mnfr。2019年6月18日提交投稿，7月22日返修意见。一共2个reviewer，第一个reviewer问了6个问题，都是一些疑问和后续研究的建议（比如建议在已经患有血栓性疾病的病人上进行探讨，我们是rct研究，对高脂血症患者进行干预了6个月，所以只能回答同意审稿人的意见，后续会作进一的探讨），没让补实验；第二个审稿人问了3个小问题，包括一个疑问和2点修改的建议，没有让补实验。editor要求2个月内返回response，我8月22号返回，8月29号就直接接收了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8bf35413988, createdName=ms5619336576777824, createdTime=Thu Dec 26 11:40:18 CST 2019, time=2019-12-26, status=1, ipAttribution=)]

2022-01-06 ms9000001896838190

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：糖尿病
经验分享：投稿一周后分配编辑，分配编辑后到现在还没有消息，请问有分配编辑是Perets, Ekaterina的嘛？一般多久能回来？谢谢

36 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2142565, encodeId=ab992142565f9, content=请问大家有碰到一个审稿人的情况吗？大修回了以后多久有结果？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de2a6480732, createdName=ms6000000386866005, createdTime=Tue Jun 13 14:48:34 CST 2023, time=2023-06-13, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1205857, encodeId=dc64120585e5c, content=请教大家一般大修回去多久收到消息呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/KUQlIP30FJNzX6JDFPic6BAPBWV3M81mdCIBnvPqW5ZkxQIYMe1JF1Q2Okn5mSJQtG4B3jkiaXyxlCrEhYbu0ickQ/0, createdBy=9e781671550, createdName=cfynocry, createdTime=Fri Mar 25 14:51:41 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2142563, encodeId=1abc214256368, content=请问有碰到只有一个审稿人的情况么？大修回去多久有消息的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de2a6480732, createdName=ms6000000386866005, createdTime=Tue Jun 13 14:45:11 CST 2023, time=2023-06-13, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=963629, encodeId=22779636292e, content=审稿速度:3.0 | 投稿命中率:50.0 | 版面费用:588.0 偏重的研究方向：肠道菌群;糖尿病 经验分享：2020年12月初投稿，半个月后要求拒稿重投。于是，2021年1月4号重新投稿，2月2号审稿意见返回，3月13号返回修改稿，4月28日接收。审稿人很细心，注重方法描述，按照审稿人的要求认真修改就好了。感恩遇到好编辑和好的审稿人！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJp0sD8Z3gbQkzM1Y9IiaGB021QlfcibqTSZ43dKewmmXh9JbSicKR8XoicPAzichzQOP3CFn9RrAmuk1w/132, createdBy=d2602052909, createdName=liyahan, createdTime=Sat May 08 09:29:15 CST 2021, time=2021-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120684, encodeId=b29c2120684ad, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47618190126, createdName=ms9000000817557932, createdTime=Tue Mar 21 05:21:25 CST 2023, time=2023-03-21, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=849818, encodeId=b72b84981857, content=投稿一个月后被拒，建议修改后重投，修改后重投之后半个月接收，编辑的意见很中肯，对实验描述要求高，可惜现在降到了2区，希望努力一下明年重回1区 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62635414138, createdName=ms5054295132918558, createdTime=Fri Feb 22 10:41:27 CST 2019, time=2019-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102200, encodeId=b3d2210220015, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：营养 经验分享：10.14日投稿，一周内送外审，11.17日拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91a75702467, createdName=ms4000001330996087, createdTime=Wed Nov 23 16:48:41 CST 2022, time=2022-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181167, encodeId=bb89118116e0b, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：糖尿病 经验分享：投稿一周后分配编辑，分配编辑后到现在还没有消息，请问有分配编辑是Perets, Ekaterina的嘛？一般多久能回来？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc4e5617036, createdName=ms9000001896838190, createdTime=Thu Jan 06 08:43:38 CST 2022, time=2022-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102205, encodeId=35aa21022054d, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：食品营养 经验分享：10.14投稿，投稿后显示 under review，一周内送审ED变为一位专家。11.17返回，拒稿。。期刊创新性要求较高，实验要求完整性较高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91a75702467, createdName=ms4000001330996087, createdTime=Wed Nov 23 16:56:29 CST 2022, time=2022-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=856211, encodeId=a43385621146, content=我的研究方向是营养活性成分与慢性病防治，data也算挺多的，一共8个figure，内容包括体外细胞实验和人群的随机对照干预试验（人群这部分只有一张figure)，之前投了atvb，第二天就秒拒了，后来改投mnfr。2019年6月18日提交投稿，7月22日返修意见。一共2个reviewer，第一个reviewer问了6个问题，都是一些疑问和后续研究的建议（比如建议在已经患有血栓性疾病的病人上进行探讨，我们是rct研究，对高脂血症患者进行干预了6个月，所以只能回答同意审稿人的意见，后续会作进一的探讨），没让补实验；第二个审稿人问了3个小问题，包括一个疑问和2点修改的建议，没有让补实验。editor要求2个月内返回response，我8月22号返回，8月29号就直接接收了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8bf35413988, createdName=ms5619336576777824, createdTime=Thu Dec 26 11:40:18 CST 2019, time=2019-12-26, status=1, ipAttribution=)]

2022-11-23 ms4000001330996087

审稿速度:1.0 | 投稿命中率:25.0
偏重的研究方向：食品营养
经验分享：10.14投稿，投稿后显示 under review，一周内送审ED变为一位专家。11.17返回，拒稿。。期刊创新性要求较高，实验要求完整性较高

15 0

[GetPortalCommentsPageByObjectIdResponse(id=2142565, encodeId=ab992142565f9, content=请问大家有碰到一个审稿人的情况吗？大修回了以后多久有结果？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de2a6480732, createdName=ms6000000386866005, createdTime=Tue Jun 13 14:48:34 CST 2023, time=2023-06-13, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=1205857, encodeId=dc64120585e5c, content=请教大家一般大修回去多久收到消息呀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=30, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/KUQlIP30FJNzX6JDFPic6BAPBWV3M81mdCIBnvPqW5ZkxQIYMe1JF1Q2Okn5mSJQtG4B3jkiaXyxlCrEhYbu0ickQ/0, createdBy=9e781671550, createdName=cfynocry, createdTime=Fri Mar 25 14:51:41 CST 2022, time=2022-03-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2142563, encodeId=1abc214256368, content=请问有碰到只有一个审稿人的情况么？大修回去多久有消息的？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=de2a6480732, createdName=ms6000000386866005, createdTime=Tue Jun 13 14:45:11 CST 2023, time=2023-06-13, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=963629, encodeId=22779636292e, content=审稿速度:3.0 | 投稿命中率:50.0 | 版面费用:588.0 偏重的研究方向：肠道菌群;糖尿病 经验分享：2020年12月初投稿，半个月后要求拒稿重投。于是，2021年1月4号重新投稿，2月2号审稿意见返回，3月13号返回修改稿，4月28日接收。审稿人很细心，注重方法描述，按照审稿人的要求认真修改就好了。感恩遇到好编辑和好的审稿人！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJp0sD8Z3gbQkzM1Y9IiaGB021QlfcibqTSZ43dKewmmXh9JbSicKR8XoicPAzichzQOP3CFn9RrAmuk1w/132, createdBy=d2602052909, createdName=liyahan, createdTime=Sat May 08 09:29:15 CST 2021, time=2021-05-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2120684, encodeId=b29c2120684ad, content=审稿速度:2.0 | 投稿命中率:75.0 经验分享：无, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47618190126, createdName=ms9000000817557932, createdTime=Tue Mar 21 05:21:25 CST 2023, time=2023-03-21, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=849818, encodeId=b72b84981857, content=投稿一个月后被拒，建议修改后重投，修改后重投之后半个月接收，编辑的意见很中肯，对实验描述要求高，可惜现在降到了2区，希望努力一下明年重回1区 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=95, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62635414138, createdName=ms5054295132918558, createdTime=Fri Feb 22 10:41:27 CST 2019, time=2019-02-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102200, encodeId=b3d2210220015, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：营养 经验分享：10.14日投稿，一周内送外审，11.17日拒稿。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91a75702467, createdName=ms4000001330996087, createdTime=Wed Nov 23 16:48:41 CST 2022, time=2022-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1181167, encodeId=bb89118116e0b, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：糖尿病 经验分享：投稿一周后分配编辑，分配编辑后到现在还没有消息，请问有分配编辑是Perets, Ekaterina的嘛？一般多久能回来？谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc4e5617036, createdName=ms9000001896838190, createdTime=Thu Jan 06 08:43:38 CST 2022, time=2022-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2102205, encodeId=35aa21022054d, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：食品营养 经验分享：10.14投稿，投稿后显示 under review，一周内送审ED变为一位专家。11.17返回，拒稿。。期刊创新性要求较高，实验要求完整性较高, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=15, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=91a75702467, createdName=ms4000001330996087, createdTime=Wed Nov 23 16:56:29 CST 2022, time=2022-11-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=856211, encodeId=a43385621146, content=我的研究方向是营养活性成分与慢性病防治，data也算挺多的，一共8个figure，内容包括体外细胞实验和人群的随机对照干预试验（人群这部分只有一张figure)，之前投了atvb，第二天就秒拒了，后来改投mnfr。2019年6月18日提交投稿，7月22日返修意见。一共2个reviewer，第一个reviewer问了6个问题，都是一些疑问和后续研究的建议（比如建议在已经患有血栓性疾病的病人上进行探讨，我们是rct研究，对高脂血症患者进行干预了6个月，所以只能回答同意审稿人的意见，后续会作进一的探讨），没让补实验；第二个审稿人问了3个小问题，包括一个疑问和2点修改的建议，没有让补实验。editor要求2个月内返回response，我8月22号返回，8月29号就直接接收了。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=98, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8bf35413988, createdName=ms5619336576777824, createdTime=Thu Dec 26 11:40:18 CST 2019, time=2019-12-26, status=1, ipAttribution=)]

2019-12-26 ms5619336576777824

我的研究方向是营养活性成分与慢性病防治，data也算挺多的，一共8个figure，内容包括体外细胞实验和人群的随机对照干预试验（人群这部分只有一张figure)，之前投了atvb，第二天就秒拒了，后来改投mnfr。2019年6月18日提交投稿，7月22日返修意见。一共2个reviewer，第一个reviewer问了6个问题，都是一些疑问和后续研究的建议（比如建议在已经患有血栓性疾病的病人上进行探讨，我们是rct研究，对高脂血症患者进行干预了6个月，所以只能回答同意审稿人的意见，后续会作进一的探讨），没让补实验；第二个审稿人问了3个小问题，包括一个疑问和2点修改的建议，没有让补实验。editor要求2个月内返回response，我8月22号返回，8月29号就直接接收了。

98 4

展开4条回复

内科

外科

专科科室

热点

按科室浏览

科研工具

写作工具

其他工具

平台业务解决方案

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务